Achilles Therapeutics plc(NASDAQ:ACHL) 
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-sma...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-09-25
P
O 0.95
H 0.96
L 0.92
C 0.96
V 309,488
10EMA 0.96
20EMA 0.96
60EMA 0.96
120EMA 0.96
250EMA 0.96